Free Trial
NASDAQ:GOSS

Gossamer Bio (GOSS) Stock Price, News & Analysis

Gossamer Bio logo
$1.23 +0.02 (+1.24%)
Closing price 07/3/2025 03:47 PM Eastern
Extended Trading
$1.23 0.00 (0.00%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Gossamer Bio Stock (NASDAQ:GOSS)

Key Stats

Today's Range
$1.20
$1.25
50-Day Range
$0.88
$1.44
52-Week Range
$0.66
$1.55
Volume
433,035 shs
Average Volume
1.46 million shs
Market Capitalization
$278.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.33
Consensus Rating
Buy

Company Overview

Gossamer Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

GOSS MarketRank™: 

Gossamer Bio scored higher than 76% of companies evaluated by MarketBeat, and ranked 826th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Gossamer Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Gossamer Bio has only been the subject of 2 research reports in the past 90 days.

  • Read more about Gossamer Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Gossamer Bio are expected to decrease in the coming year, from ($0.28) to ($0.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Gossamer Bio is -5.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Gossamer Bio is -5.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Gossamer Bio has a P/B Ratio of 9.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Gossamer Bio's valuation and earnings.
  • Percentage of Shares Shorted

    5.22% of the float of Gossamer Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Gossamer Bio has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

  • Dividend Yield

    Gossamer Bio does not currently pay a dividend.

  • Dividend Growth

    Gossamer Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.22% of the float of Gossamer Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Gossamer Bio has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

  • News Sentiment

    Gossamer Bio has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Gossamer Bio this week, compared to 2 articles on an average week.
  • Search Interest

    Only 4 people have searched for GOSS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Gossamer Bio to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Gossamer Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.70% of the stock of Gossamer Bio is held by insiders.

  • Percentage Held by Institutions

    81.23% of the stock of Gossamer Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Gossamer Bio's insider trading history.
Receive GOSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter.

GOSS Stock News Headlines

Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rally right now. Over the past few weeks alone, the yellow metal surged as high as $3,500 — the highest level on record. So far this bull run playing out exactly as me and my analysts have predicted.
See More Headlines

GOSS Stock Analysis - Frequently Asked Questions

Gossamer Bio's stock was trading at $0.9046 at the start of the year. Since then, GOSS shares have increased by 35.4% and is now trading at $1.2250.

Gossamer Bio, Inc. (NASDAQ:GOSS) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.02. The business earned $9.89 million during the quarter, compared to analysts' expectations of $3.95 million. Gossamer Bio had a negative trailing twelve-month return on equity of 128.98% and a negative net margin of 41.12%.
Read the conference call transcript
.

Gossamer Bio (GOSS) raised $230 million in an IPO on Friday, February 8th 2019. The company issued 14,400,000 shares at a price of $16.00 per share. BofA Merrill Lynch, Leerink Partners, Barclays and Evercore ISI acted as the underwriters for the IPO.

Shares of GOSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gossamer Bio investors own include Voyager Therapeutics (VYGR), Waste Connections (WCN), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/15/2025
Today
7/04/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GOSS
Fax
N/A
Employees
180
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.33
High Stock Price Target
$10.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+498.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.53 million
Pretax Margin
-40.41%

Debt

Sales & Book Value

Annual Sales
$114.70 million
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
9.42

Miscellaneous

Free Float
212,073,000
Market Cap
$278.44 million
Optionable
Optionable
Beta
1.86
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:GOSS) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners